Talkspace is budding into a digital health success story; AstraZeneca buys early-stage gene therapies from Pfizer

While Talkspace isn't yet profitable, it's starting to look like one of the success stories of the 2021 digital health boom.

July 28, 2023 Check out STAT+

Sponsored By

Stephan Melzer/Alamy STAT+ | With profitability in sight, Talkspace is budding into a digital health success story Virtual mental health company Talkspace added to its run of strong earnings reports, continuing to project it would break even by early 2024. By Mario Aguilar STAT+ | AstraZeneca buys early-stage gene therapies from Pfizer in boon for struggling field AstraZeneca will buy a group of early-stage gene therapies from Pfizer, bucking a trend of drugmakers axing programs and exiting the field. By Jason Mast STAT+ | Biogen to acquire Reata Pharmaceuticals in $7 billion deal The transaction price of $172.50 per share is a nearly 60% premium from Reata's share price at Thursday's close. By Andrew Joseph and Adam Feuerstein Keri Anderson/Netflix His book on the opioid crisis flopped in 2003. It now has a new life on Netflix Journalist Barry Meier spoke with STAT about his book and reporting on the opioid crisis that became the basis for a new Netflix show. By Bree Iskandar STAT+ | House GOP offers new plan to stem drug shortages, including cancer drug shortages House Republicans have drafted legislation to address cancer and other drug shortages that differs significantly from Democrats' approach. By John Wilkerson To detect breast cancer sooner, an MIT professor designs an ultrasound bra The device, a flexible patch that attaches to a bra via magnets, could one day be used to screen more easily for breast cancer. By Lizzy Lawrence ANGELA WEISS/AFP via Getty Images Opinion: Doctors in states that ban abortion can still refer patients elsewhere. Why are so few doing that? No state law explicitly bans the sharing of abortion information. Yet doctors are reluctant to refer patients out of state or give them info. By Michelle Oberman and Katie Watson and Lisa Lehmann

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser